These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 36561759)
1. Editorial: Immune cells and inflammatory mediators in mucosal pathologies, volume II. Leite-de-Moraes M; Chieppa M; Vermeulen M Front Immunol; 2022; 13():1092146. PubMed ID: 36561759 [No Abstract] [Full Text] [Related]
2. Editorial: Innate Immune Cells and Inflammatory Mediators in Mucosal Pathologies. Maria LD; Marcello C; Mònica V Front Immunol; 2020; 11():1679. PubMed ID: 32849584 [No Abstract] [Full Text] [Related]
3. Editorial: Immune-Epithelial Crosstalk in Inflammatory Bowel Diseases and Mucosal Wound Healing. Leppkes M; Siegmund B; Becker C Front Immunol; 2018; 9():1171. PubMed ID: 29899742 [No Abstract] [Full Text] [Related]
4. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Blumberg RS; Saubermann LJ; Strober W Curr Opin Immunol; 1999 Dec; 11(6):648-56. PubMed ID: 10631550 [TBL] [Abstract][Full Text] [Related]
5. CD14(+) macrophages that accumulate in the colon of African AIDS patients express pro-inflammatory cytokines and are responsive to lipopolysaccharide. Cassol E; Rossouw T; Malfeld S; Mahasha P; Slavik T; Seebregts C; Bond R; du Plessis J; Janssen C; Roskams T; Nevens F; Alfano M; Poli G; van der Merwe SW BMC Infect Dis; 2015 Oct; 15():430. PubMed ID: 26475133 [TBL] [Abstract][Full Text] [Related]
6. Restoration of mucosal integrity and epithelial transport function by concomitant anti-TNFα treatment in chronic DSS-induced colitis. Lenzen H; Qian J; Manns MP; Seidler U; Jörns A J Mol Med (Berl); 2018 Aug; 96(8):831-843. PubMed ID: 29967942 [TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in mucosal inflammation. Neudecker V; Yuan X; Bowser JL; Eltzschig HK J Mol Med (Berl); 2017 Sep; 95(9):935-949. PubMed ID: 28726085 [TBL] [Abstract][Full Text] [Related]
8. Indicaxanthin inhibits NADPH oxidase (NOX)-1 activation and NF-κB-dependent release of inflammatory mediators and prevents the increase of epithelial permeability in IL-1β-exposed Caco-2 cells. Tesoriere L; Attanzio A; Allegra M; Gentile C; Livrea MA Br J Nutr; 2014 Feb; 111(3):415-23. PubMed ID: 23931157 [TBL] [Abstract][Full Text] [Related]
10. [Dysregulation of mucosal immunity and inflammatory bowel diseases]. Dohi T; Kiyono H Nihon Rinsho; 1998 Jun; 56(6):1619-26. PubMed ID: 9648492 [TBL] [Abstract][Full Text] [Related]
11. The IL-1 cytokine family as custodians of barrier immunity. Matarazzo L; Hernandez Santana YE; Walsh PT; Fallon PG Cytokine; 2022 Jun; 154():155890. PubMed ID: 35462264 [TBL] [Abstract][Full Text] [Related]
12. Alterations of the mucosal immune system in inflammatory bowel disease. MacDermott RP J Gastroenterol; 1996 Dec; 31(6):907-16. PubMed ID: 9027661 [TBL] [Abstract][Full Text] [Related]
13. Cells and mediators of inflammation as effectors of epithelial repair in the inflamed intestine. Crifo B; MacNaughton WK Am J Physiol Gastrointest Liver Physiol; 2022 Jan; 322(1):G169-G182. PubMed ID: 34878937 [TBL] [Abstract][Full Text] [Related]
14. Mucosal cytokine network in inflammatory bowel disease. Andoh A; Yagi Y; Shioya M; Nishida A; Tsujikawa T; Fujiyama Y World J Gastroenterol; 2008 Sep; 14(33):5154-61. PubMed ID: 18777592 [TBL] [Abstract][Full Text] [Related]
15. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium. Pedersen G Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335 [TBL] [Abstract][Full Text] [Related]
16. Visfatin Regulates Inflammatory Mediators in Mouse Intestinal Mucosa Through Toll-Like Receptors Signaling Under Lipopolysaccharide Stress. Pang XX; Ansari AR; Yang WJ; Niu XY; Dong L; Li HZ; Xu FL; Zhang ZW; Xiao K; Hui S Arch Immunol Ther Exp (Warsz); 2021 Apr; 69(1):11. PubMed ID: 33856572 [TBL] [Abstract][Full Text] [Related]
17. Mediators of mucosal inflammation: implications for therapy. van Dullemen H; Meenan J; Stronkhorst A; Tytgat GN; van Deventer SJ Scand J Gastroenterol Suppl; 1997; 223():92-8. PubMed ID: 9200313 [TBL] [Abstract][Full Text] [Related]
18. Bacterial induction of proinflammatory cytokines in inflammatory bowel disease. Klapproth JM; Sasaki M Inflamm Bowel Dis; 2010 Dec; 16(12):2173-9. PubMed ID: 20848533 [TBL] [Abstract][Full Text] [Related]
19. MTADV 5-MER peptide suppresses chronic inflammations as well as autoimmune pathologies and unveils a new potential target-Serum Amyloid A. Hemed-Shaked M; Cowman MK; Kim JR; Huang X; Chau E; Ovadia H; Amar KO; Eshkar-Sebban L; Melamed M; Lev LB; Kedar E; Armengol J; Alemany J; Beyth S; Okon E; Kanduc D; Elgavish S; Wallach-Dayan SB; Cohen SJ; Naor D J Autoimmun; 2021 Nov; 124():102713. PubMed ID: 34390919 [TBL] [Abstract][Full Text] [Related]
20. Proinflammatory and Th2-derived cytokines modulate CD40-mediated expression of inflammatory mediators in airway epithelia: implications for the role of epithelial CD40 in airway inflammation. Propst SM; Denson R; Rothstein E; Estell K; Schwiebert LM J Immunol; 2000 Aug; 165(4):2214-21. PubMed ID: 10925309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]